薛定谔公司

最新新闻

• 评级变动
  KeyBanc Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• 评级变动
  Morgan Stanley Maintains Schrodinger(SDGR.US) With Hold Rating, Cuts Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• Morgan Stanley Maintains Schrodinger(SDGR.US) With Hold Rating, Maintains Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• 评级变动
  BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $24
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN)
  TipRanks · 2026/2/26
• 评级变动
  Morgan Stanley Maintains Schrodinger(SDGR.US) With Hold Rating, Cuts Target Price to $19
  \u5e02\u573a\u8d44\u8baf · 2026/1/8
• UBS Initiates Schrodinger(SDGR.US) With Hold Rating, Announces Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  Craig-Hallum Maintains Schrodinger(SDGR.US) With Buy Rating, Announces Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/2/26
• BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $24
  \u5e02\u573a\u8d44\u8baf · 2026/8/18
• 评级变动
  TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• 评级变动
  TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/2/26
• 评级变动
  BofA Securities Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/2/26
• 评级变动
  Craig-Hallum Maintains Schrodinger(SDGR.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/9
• 评级变动
  Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL), Contineum Therapeutics, Inc. Class A (CTNM) and Schrodinger (SDGR)
  TipRanks · 2026/5/6
• 评级变动
  UBS Downgrades Schrodinger(SDGR.US) to Hold Rating, Cuts Target Price to $13
  \u5e02\u573a\u8d44\u8baf · 2026/3/17
• 评级变动
  KeyBanc Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $25
  \u5e02\u573a\u8d44\u8baf · 2026/1/8
• 评级变动
  KeyBanc Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/4/13
• 评级变动
  TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $24
  \u5e02\u573a\u8d44\u8baf · 2026/1/8
• UBS Maintains Schrodinger(SDGR.US) With Hold Rating, Maintains Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• BofA Securities Maintains Schrodinger(SDGR.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/7

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。